feed,title,long_url,short_url
Investing,US Stocks Outpacing International Shares by Wide Margin in 2023,https://www.investing.com/analysis/us-stocks-outpacing-international-shares-by-wide-margin-in-2023-200643492,https://da.gd/k8zn
Investing,"Bitcoin's (BTC) 'Next Stop' Is $40,200, Says Analyst",https://www.investing.com/news/cryptocurrency-news/bitcoins-btc-next-stop-is-40200-says-analyst-3230816,https://da.gd/2rIgh0
Investing,47 countries pledge to authorize the crypto-asset reporting framework by 2027,https://www.investing.com/news/cryptocurrency-news/47-countries-pledge-to-authorize-the-cryptoasset-reporting-framework-by-2027-3230813,https://da.gd/el7l2d
Investing,"Earnings call: Tapestry reports record first-quarter earnings, robust growth in China, and plans for Capri Holdings acquisition",https://www.investing.com/news/stock-market-news/earnings-call-tapestry-reports-record-firstquarter-earnings-robust-growth-in-china-and-plans-for-capri-holdings-acquisition-93CH-3230773,https://da.gd/gD9be
Investing,"Earnings call: YETI Holdings reports robust Q3 2023 results, eyes international expansion",https://www.investing.com/news/stock-market-news/earnings-call-yeti-holdings-reports-robust-q3-2023-results-eyes-international-expansion-93CH-3230808,https://da.gd/DNvwN
Investing,"Earnings call: X4 Pharmaceuticals outlines plans for drug candidate mavorixafor, eyes Q2 2024 launch",https://www.investing.com/news/stock-market-news/earnings-call-x4-pharmaceuticals-outlines-plans-for-drug-candidate-mavorixafor-eyes-q2-2024-launch-93CH-3230772,https://da.gd/Csr6s
Investing,"Earnings call: Stereotaxis reports Q3 revenue rise, driven by Genesis robotic system adoption",https://www.investing.com/news/stock-market-news/earnings-call-stereotaxis-reports-q3-revenue-rise-driven-by-genesis-robotic-system-adoption-93CH-3230771,https://da.gd/H4XIt
Investing,ANI Pharmaceuticals stock falls 20% amid weak profitability and growth concerns,https://www.investing.com/news/stock-market-news/ani-pharmaceuticals-stock-falls-20-amid-weak-profitability-and-growth-concerns-93CH-3230769,https://da.gd/V2s6Lk
Investing,"Earnings call: Xeris Biopharma reports fourth consecutive quarter of robust growth, tightens 2023 revenue guidance",https://www.investing.com/news/stock-market-news/earnings-call-xeris-biopharma-reports-fourth-consecutive-quarter-of-robust-growth-tightens-2023-revenue-guidance-93CH-3230770,https://da.gd/WCa3Jy
Investing,"Earnings call: Carrols Restaurant Group reports robust Q3 results, plans expansion and digital growth",https://www.investing.com/news/stock-market-news/earnings-call-carrols-restaurant-group-reports-robust-q3-results-plans-expansion-and-digital-growth-93CH-3230768,https://da.gd/wAUjuF
Investing,"Earnings call: Xometry Reports Record Q3 Results, Launches Teamspace, and Partners with Google Cloud",https://www.investing.com/news/stock-market-news/earnings-call-xometry-reports-record-q3-results-launches-teamspace-and-partners-with-google-cloud-93CH-3230767,https://da.gd/sjO4f
Investing,Helmerich & Payne EPS surge signals potential stock climb,https://www.investing.com/news/stock-market-news/helmerich--payne-eps-surge-signals-potential-stock-climb-93CH-3230766,https://da.gd/wvmdK
Investing,"Earnings call: Ziff Davis reports Q3 2023 results, optimistic about 2024 growth",https://www.investing.com/news/stock-market-news/earnings-call-ziff-davis-reports-q3-2023-results-optimistic-about-2024-growth-93CH-3230765,https://da.gd/6w4KAF
Investing,Palladium's slide accelerates on prospects for surplus next year,https://www.investing.com/news/economy/palladiums-slide-accelerates-on-prospects-for-surplus-next-year-3230774,https://da.gd/y3l0H
